Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Raltegravir in Hiv-Infected Treatment Naive Patients in Greece.
Athanasakis, K; Boubouchairopoulou, N; Retsa, M P; Maiese, E M; Elbasha, E H; Kyriopoulos, J.
Affiliation
  • Athanasakis K; National School of Public Health, Athens, Greece.
  • Boubouchairopoulou N; National School of Public Health, Athens, Greece.
  • Retsa MP; MSD Hellas, Athens, Greece.
  • Maiese EM; Merck & Co, Inc., Whitehouse Station, NJ, USA.
  • Elbasha EH; Merck & Co, Inc, Flourtown, PA, USA.
  • Kyriopoulos J; National School of Public Health, Athens, Greece.
Value Health ; 17(7): A675, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27202485
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Greece Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Greece Country of publication: United States